iifl-logo

Kilitch Drugs India Ltd Share Price Live

Add as a Preferred Source on Google
₹186.59
(-2.09%)
Jul 31, 2026|09:01:20 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹190.58
  • Day's High₹193.9
  • 52 Wk High₹227.23
  • Prev. Close₹190.58
  • Day's Low₹185
  • 52 Wk Low ₹117.25
  • Turnover (lac)35.58
  • P/E20.33
  • Face Value₹10
  • Book Value₹95.9
  • EPS9.27
  • Mkt. Cap (Cr.)₹652.35
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Kilitch Drugs India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹190.58

Prev. Close

₹190.58

Turnover(Lac.)

₹35.58

Day's High

₹193.9

Day's Low

₹185

52 Week's High

₹227.23

52 Week's Low

₹117.25

Book Value

₹95.9

Face Value

₹10

Mkt Cap (₹ Cr.)

652.35

P/E

20.33

EPS

9.27

Divi. Yield

0

Kilitch Drugs India Ltd Corporate Action

1 Sep 2025

12:00 AM

AGM

Announcement Date: 01 Sep, 2025

arrow

18 Mar 2026

12:00 AM

Bonus

arrow

13 Aug 2025

12:00 AM

BookCloser

arrow

28 Jul 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

11 Feb 2026

12:00 AM

EGM

arrow

9 Jul 2025

12:00 AM

Rights

arrow

Kilitch Drugs (India) Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Kilitch Drugs (India) Ltd SHAREHOLDING SNAPSHOT

01 Aug, 2026|05:03 AM
Jun-2026Mar-2026Mar-2026Dec-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 63.77%

Foreign: 0.00%

Indian: 63.77%

Non-Promoter- 0.11%

Institutions: 0.11%

Non-Institutions: 36.10%

Custodian: 0.00%

Read More
Share PriceShare Price

Kilitch Drugs India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

16.08

16.08

20.58

18.08

Preference Capital

0

0

0

0

Reserves

236.86

206.84

175.35

159.95

Net Worth

252.94

222.92

195.93

178.03

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

70.01

60.76

96.41

50.45

yoy growth (%)

15.21

-36.97

91.08

79.31

Raw materials

-39.06

-35.75

-52.98

-25.9

As % of sales

55.79

58.83

54.95

51.34

Employee costs

-5.21

-5.65

-5.22

-4.21

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

7.5

5.22

19.52

7.15

Depreciation

-1.14

-1.15

-1.2

-1.19

Tax paid

-1.35

-0.76

-4.75

-0.96

Working capital

-1.1

-5.99

6.43

6.49

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

15.21

-36.97

91.08

79.31

Op profit growth

276.91

-91.66

197.85

-2,095.55

EBIT growth

39.14

-70.16

178.12

-1,655.73

Net profit growth

38.1

-69.81

138.33

-17,121.7

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

235.47

198.32

154.37

139.6

114.23

Excise Duty

0

0

0

0

0

Net Sales

235.47

198.32

154.37

139.6

114.23

Other Operating Income

0

0

0

0

0

Other Income

11.24

11.16

4.48

2.92

2.91

Kilitch Drugs India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,990.5

163.064,80,046.94608.70.84,887.2793.23

Divis Laboratories Ltd

DIVISLAB

8,056

78.182,08,140.647560.382,793629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

5,122.8

83.731,85,263.874920.694,073222.76

Cipla Ltd

CIPLA

1,473.2

36.121,18,430.12862.160.894,672.12423.36

Zydus Lifesciences Ltd

ZYDUSLIFE

1,126.8

30.151,11,271.551,7220.093,564.6237.3

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Kilitch Drugs India Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Mukund P Mehta

WTD & Executive Director

Bhavin M Mehta

Managing Director

Mira Mehta

Independent Non Exe. Director

VASUDEV KRISHNAMURTI

Independent Non Exe. Director

Venkita Subramanian Rajan

Independent Non Exe. Director

DIPEN JAYANTILAL JAIN

Company Sec. & Compli. Officer

Pushpa Nyoupane

Registered Office

C-301/2 MIDC TTC Indl Area,

Pawane Village,

Maharashtra - 400705

Tel: 91-022-27670322/27680913/65144185

Website: http://www.kilitch.com

Email: info@kilitch.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: https://in.mpms.mufg.com

Email: rnt.helpdesk@in.mpms.mufg.com

Summary

Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range ...
Read More

Reports by Kilitch Drugs India Ltd

Company FAQs

The Kilitch Drugs India Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹186.59 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kilitch Drugs India Ltd is ₹652.35 Cr. as of 31 Jul ‘26
The PE and PB ratios of Kilitch Drugs India Ltd is 20.33 and 1.98 as of 31 Jul ‘26
The 52-week high/low is the highest and lowest price at which a Kilitch Drugs India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kilitch Drugs India Ltd is ₹117.25 and ₹227.23 as of 31 Jul ‘26
Kilitch Drugs India Ltd's CAGR for 5 Years at 12.14%, 3 Years at 27.89%, 1 Year at -14.13%, 6 Month at 21.40%, 3 Month at 23.74% and 1 Month at -2.13%.
The shareholding pattern of Kilitch Drugs India Ltd is as follows:
Promoters - 63.77 %
Institutions - 0.12 %
Public - 36.11 %

QUICKLINKS FOR Kilitch Drugs India Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.